CerebralGo Plus

CerebralGo Plus is an image processing software package designed for trained medical professionals to view and process adult CT Angiography (CTA) datasets, facilitating the visualization of large head and neck vessels using DICOM-compliant images on standard hardware. The system's core algorithm, trained on Chinese data and validated on a diverse U.S. dataset of 141 images against a radiologist-derived standard, demonstrated robust quantitative performance with a Dice coefficient of 0.942 and a 95% Hausdorff Distance of 3.692.

CerebralGo Plus is a medical image management and processing software package designed for use by trained professionals, such as physicians and medical technicians. The software operates on standard 'off-the-shelf' hardware and is intended for viewing and processing DICOM compliant CT Angiography (CTA) images from adult patients. Its primary function is to visualize large vessels from head and neck CTA imaging, providing various image viewing, processing, and manipulation functions. CerebralGo Plus can interface with other DICOM-compliant systems like PACS, workstations, and CT scanners to receive CTA scans, and processed results can be sent back to PACS for viewing on workstations or via a web user interface within a hospital network. It is explicitly stated that the software is not intended for primary diagnostic use but can yield information useful in clinical decision-making when interpreted by a trained clinician. The software's algorithm was trained using images collected from China and subsequently verified using 141 images collected from the United States, ensuring the test data was independent of the training dataset. This validation dataset encompassed diverse demographic characteristics (gender, age, ethnicity) and various CT equipment manufacturers (GE, Siemens, Philips, Toshiba). A reference standard for these 141 images was established by three U.S. radiologists. Performance testing demonstrated that CerebralGo Plus met its design requirements, achieving a Dice coefficient of 0.942 and a 95% Hausdorff Distance of 3.692 when compared to the reference standard. Subgroup analyses based on scanning equipment, gender, and age also showed consistent performance.

AI Regulatory Concerns

Powered by

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

• Q1. How does the algorithm's performance, specifically the Dice coefficient and Hausdorff Distance, vary with different CT image acquisition parameters (e.g., slice thickness, contrast timing) not explicitly detailed in the subgroup analysis?; What specific image processing tools and visualization enhancements does CerebralGo Plus offer beyond basic viewing to aid clinicians in interpreting CTA datasets?; Given the algorithm was trained on Chinese datasets and validated on US images, what measures were taken to account for potential differences in patient anatomy, pathology prevalence, or imaging protocols between these populations?; What is the computational time required for CerebralGo Plus to process a typical adult CTA study, and how does this integrate into time-sensitive clinical workflows, such as stroke assessment?; Since CerebralGo Plus is not intended for primary diagnostic use, what are the specific recommended applications or adjunctive roles for this software in a clinical setting involving adult CTA imaging?